References
- Pan XL, Liu H, Wang HY, Fu SH, Liu HZ, Zhang HL, Li MH, Gao XY, Wang JL, Sun XH, et al. Emergence of genotype I of Japanese encephalitis virus as the dominant genotype in Asia. J Virol 2011; 85:9847-53; PMID:21697481; http://dx.doi.org/10.1128/JVI.00825-11
- Yu Y. Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities. Vaccine 2010; 28:3635-41; PMID:20226891; http://dx.doi.org/10.1016/j.vaccine.2010.02.105
- Bista MB, Banerjee MK, Shin SH, Tandan JB, Kim MH, Sohn YM, Ohrr HC, Tang JL, Halstead SB. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: a case control study. Lancet 2001; 358:791-5; PMID:11564484; http://dx.doi.org/10.1016/S0140-6736(01)05967-0
- Kumar R, Tripathi P, Rizvi A. Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis. N Engl J Med 2009; 360:1465-6; PMID:19339732; http://dx.doi.org/10.1056/NEJMc0808664
- Sarkar A, Banik A, Pathak BK, Mukhopadhyay SK, Chatterjee S. Envelope protein gene based molecular characterization of Japanese encephalitis virus clinical isolates from West Bengal, India: a comparative approach with respect to SA14-14-2 live attenuated vaccine strain. BMC Infect Dis 2013; 13:368; PMID:23927571; http://dx.doi.org/10.1186/1471-2334-13-368
- Hu Q, Chen B, Zhu Z, Tian J, Zhou Y, Zhang X, Zheng X. Recurrence of Japanese encephalitis epidemic in Wuhan, China, 2009-2010. PLoS One 2013; 8:e52687; PMID:23326348; http://dx.doi.org/10.1371/journal.pone.0052687
- Uchil PD, Satchidanandam V. Phylogenetic analysis of Japanese encephalitis virus: envelope gene based analysis reveals a fifth genotype, geographic clustering, and multiple introductions of the virus into the Indian subcontinent. Am J Trop Med Hyg 2001; 65:242-51; PMID:11561712
- Liu X, Yu Y, Li M, Liang G, Wang H, Jia L, Dong G. Study on the protective efficacy of SA14-14-2 attenuated Japanese encephalitis against different JE virus isolates circulating in China. Vaccine 2011; 29:2127-30; PMID:21237278; http://dx.doi.org/10.1016/j.vaccine.2010.12.108
- Erra EO, Askling HH, Yoksan S, Rombo L, Riutta J, Vene S, Lindquist L, Vapalahti O, Kantele A. Cross-protective capacity of Japanese encephalitis (JE) vaccines against circulating heterologous JE virus genotypes. Clin Infect Dis 2013; 56:267-70; PMID:23074319; http://dx.doi.org/10.1093/cid/cis883
- Fan YC, Chen JM, Chiu HC, Chen YY, Lin JW, Shih CC, Chen CM, Chang CC, Chang GJ, Chiou SS. Partially neutralizing potency against emerging genotype I virus among children received formalin-inactivated Japanese encephalitis virus vaccine. PLoS Negl Trop Dis 2012; 6:e1834; PMID:23029592; http://dx.doi.org/10.1371/journal.pntd.0001834
- Austin SK, Dowd KA, Shrestha B, Nelson CA, Edeling MA, Johnson S, Pierson TC, Diamond MS, Fremont DH. Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope. PLoS Pathog 2012; 8:e1002930; PMID:23055922; http://dx.doi.org/10.1371/journal.ppat.1002930
- Brien JD, Austin SK, Sukupolvi-Petty S, O’Brien KM, Johnson S, Fremont DH, Diamond MS. Genotype-specific neutralization and protection by antibodies against dengue virus type 3. J Virol 2010; 84:10630-43; PMID:20702644; http://dx.doi.org/10.1128/JVI.01190-10